RBOT News & Events

Vicarious Surgical announced a series of strategic actions to support a potential relisting of its common stock on a national exchange. The company said, "Over the past several months, Vicarious Surgical has implemented significant operational and cost discipline initiatives designed to align the Company's expense structure with its current stage of development while maintaining progress toward key technology milestones. As a result of these initiatives, the Company expects full-year 2026 cash burn of approximately $19 million, a substantial reduction from the approximately $35 million burn guidance provided in late 2025. In mid-2025, the Company's annual cash burn was approximately $50 million due to its operating structure. These changes reflect a significant structural improvement in the Company's cost profile, including increased use of outsourcing and operational efficiencies, while preserving progress toward key development milestones. The Company's strategic cost discipline has not slowed momentum in the development of the Vicarious Surgical System. Vicarious Surgical remains on track to achieve system design freeze by the end of 2026, a critical milestone in the Company's regulatory and commercialization roadmap. Based on its current operating plan, the Company believes that its existing cash resources provide runway through the second quarter of 2026, allowing the Company to pursue its capital markets strategy."

Vicarious Surgical announced that it received a notice from the NYSE that the NYSE has commenced the process of delisting the company's Class A common stock, par value $0.0001 per share. Trading on the company's common stock on the NYSE was suspended after market close on March 3.

The New York Stock Exchange announced that it will commence delisting procedures against Vicarious Surgical.

Vicarious Surgical announced that it has entered into a strategic partnership agreement with a global digital engineering and software development services firm. Under the agreement, the external engineering partner will assume responsibility for a significant portion of the software development activities that support the Vicarious Surgical robotic system. This includes engineering support for control systems, visualization, and key workflow components. "This agreement strengthens our ability to execute while improving the efficiency of our operating model," said Stephen From, Chief Executive Officer of Vicarious Surgical. "Partnering with an organization that has scaled programs of similar complexity allows us to focus our internal teams on core innovation, system level integration, and the work that most directly advances us toward design freeze and clinical readiness." The partner has begun onboarding through a structured transition plan that maintains continuity across all active workstreams.